What should I do if someone I care for is diagnosed with mesothelioma?

Early specialist referral to a centre with a dedicated mesothelioma multidisciplinary team is the most important first step — the new national guidelines make this explicit. Your GP can initiate the referral. Early referral also matters for legal and financial reasons: mesothelioma is almost always caused by asbestos exposure, and compensation claims — through Dust Diseases Tribunals, Comcare, or private insurance depending on the exposure context — can provide substantial support. Contact with an asbestos compensation lawyer should happen early, not after treatment decisions are made.

Is mesothelioma always related to asbestos exposure?

In Australia, yes — almost all mesothelioma cases are caused by past asbestos exposure. Because the disease has a latency period of 20 to 60 years, Australians now being diagnosed were typically exposed in the 1970s, 1980s, or 1990s in trades, naval shipyards, construction, or — for some women — through secondary exposure from the clothing of a partner or parent who worked with asbestos. Australia banned asbestos in 2003 but had one of the highest per-capita usage rates in the world prior to that.

Australia's mesothelioma care gets its first overhaul in 13 years

What just happened

Australia’s first national mesothelioma clinical guideline update in 13 years was released this week, changing the standard of care for one of the country’s most asbestos-linked cancers in several meaningful ways.

Developed by the Australian Data and Digital Research Institute with input from more than 30 specialists across oncology, surgery, pathology, and palliative care, the guidelines establish nationally consistent standards for pleural mesothelioma management. The last major update was in 2013 — before immune checkpoint inhibitors had entered the clinical picture.

For most people reading this, mesothelioma is not your story right now. But in Australia, it may be your father’s story. Your partner’s. Your uncle’s. The man who spent the 1980s in the shipyard, the builder who stripped ceilings in renovation-era houses. The disease has a latency period of 20 to 60 years — meaning the exposure wave from Australian worksites in the 1970s and 1980s is still producing new diagnoses today.

The both-and

What has actually changed

The most clinically significant shift is in first-line treatment. Immune checkpoint inhibitors are now the standard first-line approach for unresectable pleural mesothelioma, replacing the older chemotherapy-dominated model. Platinum-pemetrexed chemotherapy remains appropriate for selected patients depending on histological subtype and performance status — but the treatment landscape has materially changed, and the guidelines now reflect the evidence.

Diagnostically, the update integrates modern immunohistochemistry and molecular testing into routine pathology assessment, and introduces structured synoptic reporting to standardise capture of prognostic information. These changes matter because mesothelioma diagnosis has historically been delayed and inconsistent — the disease mimics other pleural conditions, and pathology was not always structured in a way that captured the markers needed to guide treatment decisions.

The guidelines also make early palliative care integration an explicit recommendation — beginning from diagnosis, not when curative options have been exhausted. This is a meaningful shift from older models where palliative care was positioned as a last resort.

Australia’s unique asbestos burden

Lung Foundation Australia describes mesothelioma as one of the most devastating asbestos-related diseases — always fatal, with a median survival that historically measured in months. Australia has one of the highest mesothelioma incidence rates in the world per capita, a direct legacy of asbestos usage that peaked here in the 1970s across construction, naval shipbuilding, and manufacturing.

Despite a 2003 ban on asbestos use and import, nearly 700 Australians are diagnosed with mesothelioma every year. The Asbestos Diseases Research Institute notes that Australia’s asbestos-related disease burden will not peak until the late 2020s or early 2030s — the latency is that long. The exposure decisions of 40 or 50 years ago are still presenting at GP surgeries today.

For women specifically: secondary asbestos exposure — through washing the work clothes of a partner, parent, or sibling who handled asbestos — is a documented and underrecognised route to mesothelioma. It has historically been less common than occupational exposure but is not rare.

The GP’s role under the new framework

The guidelines clarify and strengthen the GP’s referral role:

Prompt referral to specialist centres with dedicated mesothelioma multidisciplinary teams — not deferred, not watched
Early palliative care engagement alongside active treatment
Telehealth and virtual multidisciplinary team meetings to reduce the geographic inequality inherent in a disease that affects working-class and regional Australians disproportionately
Early connection with asbestos compensation lawyers — the guidelines explicitly include this as part of coordinated management, recognising that compensation processes are time-sensitive and that patients navigating diagnosis and treatment simultaneously often miss the legal window

That last point is clinically and humanly important. Asbestos compensation in Australia operates through state Dust Diseases Tribunals, Comcare, and private insurance claims depending on where and when the exposure occurred. These claims take time, and the treatment trajectory for mesothelioma can be rapid. GPs who know to raise compensation options early — not after the acute phase has passed — provide a material service to their patients and families.

My two cents

This guideline update matters for most GPs in Australia for one reason: we are still in the asbestos latency window. The builder who spent three decades handling asbestos cement sheets before the 2003 ban is now in his 60s and 70s, and is presenting to general practice. The naval shipbuilder, the auto-mechanic, the woman whose husband worked in construction and whose work clothes she laundered for 20 years — all of them carry exposure risk that may still be clinically relevant.

A diagnosis of pleural mesothelioma in 2026 is not the same clinical picture it was in 2013. Immune checkpoint inhibitors have changed the treatment options in a disease where options were previously very limited. The updated guidelines give GPs the framework to move faster toward specialist referral and to raise compensation options early — before the patient or their family has to think to ask.

If you have a family member with unexplained persistent pleural effusion, breathlessness, or chest wall pain — particularly with a history of occupational or secondary asbestos exposure — that conversation warrants a GP visit where the word mesothelioma is explicitly part of the differential.

Verdict: yes — worth knowing about.

Sources cited

National mesothelioma guideline redraws care. The Medical Republic, 20 July 2026. https://www.medicalrepublic.com.au/national-mesothelioma-guideline-redraws-care/127457
Lung Foundation Australia — Mesothelioma. https://lungfoundation.com.au/patients-carers/living-with-lung-disease/mesothelioma/
Asbestos Diseases Research Institute. https://www.adri.org.au